Key Takeaways
- The most common semaglutide side effects are gastrointestinal — nausea, diarrhea, vomiting, and constipation — and they were the leading complaints in the STEP 1 trial.
- They tend to be worst early and after each dose increase, then settle. Slow titration exists specifically to blunt them.
- Serious but uncommon risks include pancreatitis, gallbladder problems, and a boxed warning about thyroid C-cell tumors (seen in rodents).
- Most side effects are manageable with smaller, lower-fat meals, hydration, and a slower dose schedule if needed.
- This is general education. Report anything severe or persistent to your prescriber, and never adjust your dose on your own.
What semaglutide is
Semaglutide is a GLP-1 receptor agonist sold as Wegovy (weight management) and Ozempic and Rybelsus (type 2 diabetes). It works by mimicking the gut hormone GLP-1 — slowing stomach emptying and reducing appetite. That same mechanism is why the side effects are mostly digestive. For the full drug overview, see our semaglutide profile.
Common side effects
These are the effects most people notice. They are usually mild to moderate and improve with time.
- Nausea — the most common. It is typically worst in the first days after starting or increasing the dose.
- Diarrhea and constipation — many people get one or the other; some alternate.
- Vomiting — less common than nausea but does occur, especially early.
- Abdominal pain, indigestion, bloating, and burping.
- Reduced appetite — this is partly the intended effect, but it can tip into eating too little.
- Fatigue, headache, and dizziness — often tied to eating and drinking less than usual.
In the STEP 1 obesity trial, gastrointestinal effects were the most frequently reported side effects, and nausea led the list (STEP 1, NEJM). The Wegovy prescribing information lists these gut effects, along with headache, fatigue, dizziness, and bloating, among reactions occurring in 5% or more of people.
Serious side effects to know
These are uncommon, but you should know the warning signs.
- Pancreatitis (inflammation of the pancreas). Severe, persistent abdominal pain — often radiating to the back and sometimes with vomiting — warrants urgent medical care.
- Gallbladder problems. Rapid weight loss itself raises gallstone risk. Pain in the upper-right abdomen, fever, or yellowing of the skin or eyes needs evaluation.
- Kidney injury from dehydration. Ongoing vomiting or diarrhea can dehydrate you enough to stress the kidneys — a reason to take fluid intake seriously.
- Thyroid C-cell tumors (boxed warning). Semaglutide caused thyroid tumors in rodents; whether it does in humans is not established. It is contraindicated if you or a close relative have had medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (Ozempic label).
- Low blood sugar (hypoglycemia). Uncommon on its own, but more likely if you also take insulin or a sulfonylurea for diabetes.
- Allergic reactions and diabetic retinopathy changes are also noted in the labeling.
None of these are reasons to fear the drug — they are reasons to know which symptoms mean “call now” rather than “wait it out.”
How to manage the common ones
Most people can make the first months much easier with a few habits:
- Eat smaller, more frequent meals instead of large ones. A full stomach on a drug that slows emptying is a recipe for nausea.
- Go easy on fat and fried foods, which slow stomach emptying further and are strongly linked to worse nausea.
- Stop at the first sign of fullness. On semaglutide, fullness arrives sooner and eating past it commonly triggers nausea or vomiting.
- Hydrate, and keep fluids up if you have any diarrhea or vomiting.
- Protect protein and total calories. The appetite drop makes under-eating easy, which worsens fatigue and costs you muscle — see Protein First and our nutrition guides.
- Ask about slowing the titration. If a dose step hits hard, prescribers can often hold or slow it rather than push through.
When to contact your clinician
Reach out promptly for severe or persistent abdominal pain, signs of dehydration, symptoms of a gallbladder or pancreas problem, an allergic reaction, or any new severe symptom. And because the choice between GLP-1 drugs affects side-effect tolerance, our Wegovy vs. Zepbound comparison covers how semaglutide’s profile stacks up against tirzepatide’s.
This article is general information, not a substitute for the prescribing information or your clinician’s advice. See our editorial policy for how it is sourced and reviewed.